|
US5853719A
(en)
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
|
US7585622B1
(en)
*
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
|
US6475789B1
(en)
*
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
|
AU4803697A
(en)
|
1996-10-01 |
1998-04-24 |
Geron Corporation |
Telomerase reverse transcriptase
|
|
US6251665B1
(en)
|
1997-02-07 |
2001-06-26 |
Cem Cezayirli |
Directed maturation of stem cells and production of programmable antigen presenting dentritic cells therefrom
|
|
US6228640B1
(en)
|
1997-02-07 |
2001-05-08 |
Cem Cezayirli |
Programmable antigen presenting cell of CD34 lineage
|
|
US6977073B1
(en)
|
1997-02-07 |
2005-12-20 |
Cem Cezayirli |
Method for stimulating an immune response
|
|
US20020041868A1
(en)
*
|
1997-04-15 |
2002-04-11 |
Charles Nicolette |
Cell fusions and methods of making and using the same
|
|
US20050169898A1
(en)
*
|
1997-04-15 |
2005-08-04 |
Jianlin Gong |
Cell fusions and methods of making and using the same
|
|
US7413864B2
(en)
*
|
1997-04-18 |
2008-08-19 |
Geron Corporation |
Treating cancer using a telomerase vaccine
|
|
US7622549B2
(en)
*
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
|
US6977074B2
(en)
*
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
US6337200B1
(en)
*
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
|
US7402307B2
(en)
*
|
1998-03-31 |
2008-07-22 |
Geron Corporation |
Method for identifying and killing cancer cells
|
|
JP2002509716A
(ja)
|
1998-03-31 |
2002-04-02 |
ユニバーシティ テクノロジー コーポレイション |
テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物
|
|
US20040247662A1
(en)
*
|
1998-06-25 |
2004-12-09 |
Dow Steven W. |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
US20030022854A1
(en)
*
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
|
FR2785542B1
(fr)
*
|
1998-11-06 |
2001-02-09 |
Pf Medicament |
UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE D'UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE QUI LUI EST ASSOCIEE VERS LES CELLULES PRESENTATRICES D'ANTIGENES TELLES QUE LES CELLULES DENDRITIQUES HUMAINES
|
|
US7713739B1
(en)
|
2000-11-17 |
2010-05-11 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticle-based transfection and activation of dendritic cells
|
|
US7015204B1
(en)
|
1999-10-07 |
2006-03-21 |
Cornell Research Foundation, Inc. |
Protective immunity or immunological tolerance induced with RNA particularly total cellular RNA
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
US6783939B2
(en)
*
|
2000-07-07 |
2004-08-31 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
|
|
AU2002258379A1
(en)
*
|
2000-10-24 |
2002-09-19 |
Whitehead Institute For Biomedical Research |
Response of dendritic cells to a diverse set of pathogens
|
|
EP1363931A4
(en)
*
|
2001-02-01 |
2004-04-07 |
Tanox Inc |
METHODS OF PRODUCING AND IDENTIFYING MONOCLONAL ANTIBODIES DIRECTED AGAINST A LARGE NUMBER OF HUMAN ANTIGENS
|
|
DE10112851C1
(de)
|
2001-03-16 |
2002-10-10 |
Gsf Forschungszentrum Umwelt |
Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen
|
|
WO2002087627A1
(en)
*
|
2001-04-27 |
2002-11-07 |
Xcyte Therapies, Inc. |
Maturation of antigen-presenting cells using activated t cells
|
|
GB0111015D0
(en)
*
|
2001-05-04 |
2001-06-27 |
Norsk Hydro As |
Genetic material
|
|
ES2356934T3
(es)
|
2001-06-05 |
2011-04-14 |
Curevac Gmbh |
ARNm ESTABILIZADO CON UN CONTENIDO DE G/C AUMENTADO QUE CODIFICA PARA UN ANTÍGENO VIRAL.
|
|
EP1432791B2
(en)
*
|
2001-09-06 |
2013-10-23 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
|
WO2003029433A2
(en)
*
|
2001-10-04 |
2003-04-10 |
Aguilar-Cordova Carlos Estuard |
Chimeric viral vectors for gene therapy
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
KR20050047518A
(ko)
*
|
2002-07-05 |
2005-05-20 |
듀크 유니버시티 |
혈관 면역요법
|
|
WO2004016803A2
(en)
*
|
2002-08-14 |
2004-02-26 |
Duke University |
Method of enhancing cd4+ t cell responses
|
|
DE60327786D1
(de)
|
2002-09-12 |
2009-07-09 |
Oncotherapy Science Inc |
Kdr-peptide und diese enthaltende impfstoffe
|
|
US7785583B2
(en)
*
|
2002-12-10 |
2010-08-31 |
Argos Therapeutics, Inc. |
In situ maturation of dendritic cells
|
|
CA2509973C
(en)
|
2002-12-13 |
2013-02-26 |
Alphavax, Inc. |
Multi-antigenic alphavirus replicon particles and methods
|
|
CA2509979C
(en)
*
|
2002-12-13 |
2013-02-26 |
Alphavax, Inc. |
Alphavirus particles and methods for preparation
|
|
JP2006518219A
(ja)
*
|
2003-02-18 |
2006-08-10 |
マックスサイト インコーポレーティッド |
電気穿孔法による細胞への抗原の負荷方法
|
|
US20060134067A1
(en)
*
|
2003-02-18 |
2006-06-22 |
Maxcyte, Inc. |
Loading of cells with antigens by electroporation
|
|
EP2557164A1
(en)
*
|
2003-02-18 |
2013-02-13 |
Kevin M. Slawin |
Induced activation in dendritic cells
|
|
CN1791678A
(zh)
*
|
2003-03-20 |
2006-06-21 |
阿尔法瓦克斯公司 |
改进的甲病毒复制子和辅助构建体
|
|
DK1651666T3
(da)
*
|
2003-07-11 |
2009-08-31 |
Alphavax Inc |
Alfavirus-baserede cytomegalovirusvacciner
|
|
DE10335833A1
(de)
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
|
KR20060126516A
(ko)
*
|
2003-11-25 |
2006-12-07 |
아르고스 쎄라퓨틱스 인코포레이티드 |
Ｍｒｎａ로 전달이입된 항원제시세포
|
|
US20050181035A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Dow Steven W. |
Systemic immune activation method using non CpG nucleic acids
|
|
EP1730263A4
(en)
*
|
2004-03-02 |
2008-01-23 |
Tsuneya Ohno |
METHODS AND COMPOSITIONS RELATING TO HYBRID CELL VACCINES FOR TREATMENT AND CANCER PREVENTION
|
|
PT1751289E
(pt)
|
2004-05-18 |
2009-03-31 |
Alphavax Inc |
Vectores de alfavirais derivados da tc-83, partículas e métodos
|
|
WO2005116261A2
(en)
*
|
2004-05-24 |
2005-12-08 |
Albert Einstein College Of Medecine Of Yeshiva University |
Rna expression microarrays
|
|
CA2504451A1
(en)
*
|
2004-08-10 |
2006-02-10 |
Geron Corporation |
Dendritic cell vaccines for treating cancer made from embryonic stem cells
|
|
AU2005284922B2
(en)
|
2004-09-14 |
2010-12-23 |
Coimmune, Inc. |
Strain independent amplification of pathogens and vaccines thereto
|
|
US8076132B2
(en)
|
2004-09-17 |
2011-12-13 |
Hasumi International Research Foundation |
Dendritic cell tumor injection (DCTI) therapy
|
|
US20060216269A1
(en)
*
|
2004-09-17 |
2006-09-28 |
Kenichiro Hasumi |
Dendritic cell tumor injection (DCTI) therapy
|
|
GB0501129D0
(en)
*
|
2005-01-19 |
2005-02-23 |
Ribostem Ltd |
Method of treatment by administration of RNA
|
|
DK2325306T3
(en)
|
2005-02-25 |
2014-03-03 |
Oncotherapy Science Inc |
Peptide vaccines against lung cancers expressing TTK, URLC10 or KOC1 polypeptide
|
|
EP2095822B1
(en)
|
2005-02-28 |
2013-10-16 |
Oncotherapy Science, Inc. |
Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
|
|
KR20160045151A
(ko)
|
2005-04-08 |
2016-04-26 |
아르고스 쎄라퓨틱스 인코포레이티드 |
수지상 세포 조성물 및 방법
|
|
BRPI0613970B8
(pt)
|
2005-07-27 |
2021-05-25 |
Oncotherapy Science Inc |
composição para o tratamento ou para a prevenção de câncer de cólon compreende uma quantidade farmaceuticamente eficaz de um sirna contra um polinucleotídeo de tom 34
|
|
US8765687B2
(en)
|
2005-10-17 |
2014-07-01 |
Sloan Kettering Institute For Cancer Research |
WT1 HLA class II-binding peptides and compositions and methods comprising same
|
|
EP3117836A1
(en)
|
2006-04-10 |
2017-01-18 |
Sloan Kettering Institute For Cancer Research |
Immunogenic wt-1 peptides and uses thereof
|
|
AU2007238624B2
(en)
|
2006-04-14 |
2012-05-31 |
Cellscript, Llc |
Kits and methods for generating 5' capped RNA
|
|
CN101484461B
(zh)
|
2006-08-18 |
2014-09-17 |
阿哥斯医疗公司 |
Cd83在联合治疗中的用途
|
|
BRPI0717651A2
(pt)
|
2006-10-17 |
2013-12-24 |
Oncotherapy Science Inc |
Vacinas de peptídeo para cânceres que expressam polipeptídeos mphosph1 ou depdc1
|
|
CA3058450A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Baylor College Of Medicine |
Generating an immune response by inducing cd40 and pattern recognition receptors
|
|
WO2008055354A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Université de Montréal |
Rna-loaded dendritic cell compositions for eliciting cd4+ t cell help and related methods
|
|
TWI615403B
(zh)
|
2007-02-21 |
2018-02-21 |
腫瘤療法 科學股份有限公司 |
表現腫瘤相關抗原之癌症的胜肽疫苗
|
|
TW201425333A
(zh)
|
2007-04-11 |
2014-07-01 |
Oncotherapy Science Inc |
腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗
|
|
EP2947149B1
(en)
|
2007-06-21 |
2018-02-28 |
Alphavax, Inc. |
Alphavirus replicon particles for use in vaccination
|
|
EP3263585B1
(en)
|
2007-08-20 |
2022-01-19 |
Oncotherapy Science, Inc. |
Foxm1 peptide and medicinal agent comprising the same
|
|
US8513208B2
(en)
*
|
2008-02-28 |
2013-08-20 |
Argos Therapeutics, Inc. |
Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection
|
|
EP3766517B1
(en)
|
2008-06-20 |
2022-11-02 |
Duke University |
Compositions, methods, and kits for eliciting an immune response
|
|
AU2009292996B2
(en)
|
2008-09-22 |
2015-04-23 |
Baylor College Of Medicine |
Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters
|
|
JP6069755B2
(ja)
|
2008-11-24 |
2017-02-01 |
ヘルムホルツ・ツェントルム・ミュンヘン・ドイチェス・フォーシュンクスツェントルム・フュア・ゲズントハイト・ウント・ウンベルト・ゲーエムベーハー |
高親和性ｔ細胞受容体およびその用途
|
|
TWI539160B
(zh)
|
2008-12-05 |
2016-06-21 |
腫瘤療法 科學股份有限公司 |
Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗
|
|
WO2010065876A2
(en)
|
2008-12-06 |
2010-06-10 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions related to th-1 dendritic cells
|
|
TWI469791B
(zh)
|
2009-02-18 |
2015-01-21 |
Oncotherapy Science Inc |
Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
|
|
US9841426B2
(en)
*
|
2009-03-11 |
2017-12-12 |
Marker Gene Technologies, Inc |
Intracellular organelle peptide targeted enzyme substrates
|
|
NZ594198A
(en)
|
2009-03-18 |
2013-11-29 |
Oncotherapy Science Inc |
Neil3 peptides and vaccines including the same
|
|
TWI507204B
(zh)
|
2009-05-26 |
2015-11-11 |
Oncotherapy Science Inc |
Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
|
|
TW201136604A
(en)
|
2009-12-14 |
2011-11-01 |
Oncotherapy Science Inc |
TMEM22 peptides and vaccines including the same
|
|
EP2545171B1
(en)
|
2010-03-11 |
2017-12-20 |
OncoTherapy Science, Inc. |
Hjurp peptides and vaccines including the same
|
|
TW201627003A
(zh)
|
2010-04-02 |
2016-08-01 |
腫瘤療法 科學股份有限公司 |
Ｅｃｔ２胜肽及含此胜肽之疫苗
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2622064B1
(en)
|
2010-10-01 |
2019-05-29 |
Modernatx, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
US8710200B2
(en)
|
2011-03-31 |
2014-04-29 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids encoding a modified erythropoietin and their expression
|
|
EP2557089A2
(en)
|
2011-07-15 |
2013-02-13 |
Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Compositions and methods for immunomodulation
|
|
DK2742133T3
(en)
|
2011-08-12 |
2017-12-04 |
Oncotherapy Science Inc |
MPHOSPH1 PEPTIDES AND VACCINES CONTAINING THESE
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP3492109B1
(en)
|
2011-10-03 |
2020-03-04 |
ModernaTX, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
DK3296317T3
(da)
|
2011-10-28 |
2020-02-24 |
Oncotherapy Science Inc |
Topk-peptider og vacciner, der indbefatter disse
|
|
HRP20220717T1
(hr)
|
2011-12-16 |
2022-07-22 |
Modernatx, Inc. |
Modificirani pripravci mrna
|
|
CA2861206C
(en)
|
2012-01-13 |
2021-07-06 |
Richard J. O'reilly |
Immunogenic wt-1 peptides and methods of use thereof
|
|
WO2013151665A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
JP6259983B2
(ja)
|
2012-07-10 |
2018-01-17 |
オンコセラピー・サイエンス株式会社 |
Ｔｈ１細胞のＫＩＦ２０Ａエピトープペプチドおよびこれを含有するワクチン
|
|
US9597380B2
(en)
|
2012-11-26 |
2017-03-21 |
Modernatx, Inc. |
Terminally modified RNA
|
|
PL2945647T3
(pl)
|
2013-01-15 |
2021-03-08 |
Memorial Sloan Kettering Cancer Center |
Immunogenne peptydy wt-1 i sposoby ich zastosowania
|
|
US10815273B2
(en)
|
2013-01-15 |
2020-10-27 |
Memorial Sloan Kettering Cancer Center |
Immunogenic WT-1 peptides and methods of use thereof
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
TWI658049B
(zh)
|
2013-03-12 |
2019-05-01 |
腫瘤療法 科學股份有限公司 |
Ｋｎｔｃ２胜肽及含此胜肽之疫苗
|
|
EP2968502B1
(en)
|
2013-03-14 |
2020-08-26 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlling t cell proliferation
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
EP3004329B1
(en)
|
2013-06-05 |
2020-03-04 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing partial apoptosis using caspase polypeptides
|
|
EP3049092A4
(en)
|
2013-09-24 |
2017-09-06 |
Duke University |
Compositions, methods and kits for eliciting an immune response
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
SG11201602503TA
(en)
|
2013-10-03 |
2016-04-28 |
Moderna Therapeutics Inc |
Polynucleotides encoding low density lipoprotein receptor
|
|
WO2015062738A1
(en)
|
2013-11-01 |
2015-05-07 |
Curevac Gmbh |
Modified rna with decreased immunostimulatory properties
|
|
JP6772063B2
(ja)
|
2014-02-14 |
2020-10-21 |
ベリカム ファーマシューティカルズ， インコーポレイテッド |
誘導可能なキメラポリペプチドを使用して細胞を活性化するための方法
|
|
US12214038B2
(en)
*
|
2014-07-22 |
2025-02-04 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for cancer immunotherapy
|
|
SG11201700839SA
(en)
|
2014-08-04 |
2017-03-30 |
Oncotherapy Science Inc |
Cdca1-derived peptide and vaccine containing same
|
|
CN111925414B
(zh)
|
2014-08-04 |
2025-04-18 |
肿瘤疗法科学股份有限公司 |
Koc1衍生的肽和包含它们的疫苗
|
|
SG10201900835XA
(en)
|
2014-08-04 |
2019-03-28 |
Oncotherapy Science Inc |
Urlc10-derived peptide and vaccine containing same
|
|
EP3189148A4
(en)
|
2014-09-02 |
2018-05-02 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by myd88 and cd40 polypeptides
|
|
JP7029294B2
(ja)
*
|
2014-09-17 |
2022-03-03 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
抗原特異的ｔ細胞を同定、濃縮、及び／または増殖させるための試薬及び方法
|
|
MX389823B
(es)
|
2014-10-27 |
2025-03-20 |
Fred Hutchinson Cancer Center |
Composiciones y metodos para reforzar la eficacia de inmunoterapia celular adoptiva.
|
|
EP3215522B1
(en)
|
2014-11-03 |
2021-12-01 |
Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum |
T cell receptors directed against bob1 and uses thereof
|
|
JP2018090491A
(ja)
*
|
2015-04-01 |
2018-06-14 |
株式会社細胞治療技術研究所 |
癌ワクチンの製造方法、及び癌ワクチン
|
|
US11090332B2
(en)
*
|
2015-05-21 |
2021-08-17 |
Regen BioPharma, Inc. |
Antigen specific mRNA cellular cancer vaccines
|
|
JP6666094B2
(ja)
*
|
2015-09-15 |
2020-03-13 |
株式会社東芝 |
吸着支持装置、および物品把持装置
|
|
BR112018005581A2
(pt)
|
2015-10-08 |
2018-10-16 |
Oncotherapy Science, Inc. |
peptídeo derivado de foxm1 e vacina incluindo o mesmo
|
|
EP3410849B1
(en)
|
2016-02-05 |
2023-07-05 |
Institut Pasteur |
Use of inhibitors of adam12 as adjuvants in tumor therapies
|
|
US11723962B2
(en)
|
2016-05-04 |
2023-08-15 |
Fred Hutchinson Cancer Center |
Cell-based neoantigen vaccines and uses thereof
|
|
JP2019519589A
(ja)
*
|
2016-06-29 |
2019-07-11 |
デューク ユニバーシティー |
キメラポリオウイルスで抗原提示細胞を活性化するための組成物及び方法
|
|
CN111818940A
(zh)
*
|
2018-01-05 |
2020-10-23 |
安德烈亚斯·罗尔夫-乔纳斯·尼尔森 |
用作疫苗的内源性肿瘤衍生的环状rna及其蛋白质
|
|
TW202023581A
(zh)
|
2018-08-02 |
2020-07-01 |
日商腫瘤療法 科學股份有限公司 |
來自cdca1的胜肽及含有此的疫苗
|
|
US20250144143A1
(en)
*
|
2023-11-06 |
2025-05-08 |
Immunitybio, Inc. |
Virally Educated T cells
|